Pharmafile Logo
Pharmafocus logo
Advanced Search

vimizin

Showing 3 posts of 3 posts found.

location-shanbally

FDA approves BioMarin’s Irish facility

June 13, 2017
Manufacturing and Production BioMarin, Ireland, cork, vimizin

The FDA has approved BioMarin’s bulk biologic manufacturing plant, based in Cork, Ireland. The facility will manufacture an ingredient of …

News

New final NICE guidance on AbbVie, BMS, Pfizer and Roche drugs

December 16, 2015
Sales and Marketing BioMarin Pharma, Enbrel, Humira, Ikervis, MPS IVa, NICE, NICE guidance, Orencia, RoActemra, Santen, apremilast, ciclosporin, dry eye syndrome, juvenile idiopathic arthritis, otezla, psoriatic arthritis, vimizin

NICE has published final guidance on several drugs, approving therapies for juvenile idiopathic arthritis, dry eye disease and Morquio A …

News
Biomarin image

Vimizin shown green light

February 19, 2014
Research and Development, Sales and Marketing BioMarin, FDA, congenital enzyme disorder, vimizin

Regulators have shown the green light to BioMarin Pharmaceutical’s Vimizim as a treatment for a rare enzyme deficiency which affects …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025